These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 36009576)

  • 1. Biomarkers in Anal Cancer: Current Status in Diagnosis, Disease Progression and Therapeutic Strategies.
    Mathias-Machado MC; Peixoto RD; Moniz CMV; Jácome AA
    Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging and Experimental Agents for Anal Cancer: What is New?
    Farias JPF; Rangel da Silva MHC; Jácome AA
    J Exp Pharmacol; 2021; 13():433-440. PubMed ID: 33859504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Genomic Profiling of Metastatic Squamous Cell Carcinoma of the Anal Canal.
    Morris V; Rao X; Pickering C; Foo WC; Rashid A; Eterovic K; Kim T; Chen K; Wang J; Shaw K; Eng C
    Mol Cancer Res; 2017 Nov; 15(11):1542-1550. PubMed ID: 28784613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Immunotherapy in the Treatment of Anal Cancer and Future Strategies.
    Jácome AA; Morris VK; Eng C
    Curr Treat Options Oncol; 2022 Aug; 23(8):1073-1085. PubMed ID: 35666353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Advances in the Management of Anal Cancer.
    Upadhyay L; Hartzell M; Parikh AR; Strickland MR; Klempner S; Malla M
    Healthcare (Basel); 2023 Nov; 11(23):. PubMed ID: 38063578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological Checkpoint Blockade in Anal Squamous Cell Carcinoma: Dramatic Responses Tempered By Frequent Resistance.
    Jayakrishnan T; Yadav D; Huffman BM; Cleary JM
    Curr Oncol Rep; 2024 Jun; ():. PubMed ID: 38861124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The promise of immunotherapy in anal squamous cell carcinoma: a novel approach for an orphan disease.
    Johnson B; Eng C
    Clin Adv Hematol Oncol; 2017 Dec; 15(12):968-961. PubMed ID: 29315288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of squamous cell carcinoma of the anal canal.
    Armstrong SA; Malley R; Wang H; Lenz HJ; Arguello D; El-Deiry WS; Xiu J; Gatalica Z; Hwang JJ; Philip PA; Shields AF; Marshall JL; Salem ME; Weinberg BA
    J Gastrointest Oncol; 2021 Oct; 12(5):2423-2437. PubMed ID: 34790403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated risk of human papillomavirus-related second cancers in survivors of anal canal cancer.
    Nelson RA; Lai LL
    Cancer; 2017 Oct; 123(20):4013-4021. PubMed ID: 28608917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal management of squamous cell carcinoma of the anal canal: where are we now?
    Eng C; Ahmed S
    Expert Rev Anticancer Ther; 2014 Aug; 14(8):877-86. PubMed ID: 24981728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic and Predictive Markers for Patients With Anal Cancer.
    Holliday EB; Peddireddy A; Morris VK
    J Natl Compr Canc Netw; 2023 Jun; 21(6):678-684. PubMed ID: 37308122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic role of HPV integration status and molecular profile in advanced anal carcinoma: An ancillary study to the epitopes-HPV02 trial.
    Debernardi A; Meurisse A; Prétet JL; Guenat D; Monnien F; Spehner L; Vienot A; Roncarati P; André T; Abramowitz L; Molimard C; Mougin C; Herfs M; Kim S; Borg C
    Front Oncol; 2022; 12():941676. PubMed ID: 36313663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Management and Prevention of Anal Squamous Cell Carcinoma.
    Eng C; Messick C; Glynne-Jones R
    Am Soc Clin Oncol Educ Book; 2019 Jan; 39():216-225. PubMed ID: 31099616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy in advanced anal cancer: Is the beginning of a new era?
    Ciardiello D; Guerrera LP; Maiorano BA; Parente P; Latiano TP; Di Maio M; Ciardiello F; Troiani T; Martinelli E; Maiello E
    Cancer Treat Rev; 2022 Apr; 105():102373. PubMed ID: 35279535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Squamous cell anal carcinoma. What's next ?].
    Kim S; Spehner L; Cabel L; Bidard FC; Borg C
    Bull Cancer; 2021 Jan; 108(1):80-89. PubMed ID: 33423780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental and investigational drugs for the treatment of anal cancer.
    Jacome AA; Eng C
    Expert Opin Investig Drugs; 2018 Dec; 27(12):941-950. PubMed ID: 30381968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy in Anal Cancer.
    Phuong L; Rajdev L
    Curr Oncol Rep; 2020 Jul; 22(9):94. PubMed ID: 32651760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy of Anal Cancer.
    Rogers JE; Eng C
    Drugs; 2017 Sep; 77(14):1519-1530. PubMed ID: 28770514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in the treatment of anal cancer: an overview of the latest investigational drugs.
    Yu J; Kim RD
    Expert Opin Investig Drugs; 2024 Feb; 33(2):145-157. PubMed ID: 38275174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Docetaxel, Cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: a phase II study of French interdisciplinary GERCOR and FFCD groups (Epitopes-HPV02 study).
    Kim S; Jary M; André T; Vendrely V; Buecher B; François E; Bidard FC; Dumont S; Samalin E; Peiffert D; Pernot S; Baba-Hamed N; El Hajbi F; Bouché O; Desrame J; Parzy A; Zoubir M; Louvet C; Bachet JB; Nguyen T; Abdelghani MB; Smith D; De La Fouchardière C; Aparicio T; Bennouna J; Gornet JM; Jacquin M; Bonnetain F; Borg C
    BMC Cancer; 2017 Aug; 17(1):574. PubMed ID: 28841909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.